Virokine

From Wikipedia, the free encyclopedia

This article or section is in need of attention from an expert on the subject.
Please help recruit one or improve this article yourself. See the talk page for details.
Please consider using {{Expert-subject}} to associate this request with a WikiProject

A virokine is a competitive inhibitor of a cytokine encoded within some viral genomes.

The word "virokine" was originally coined by Dr. Bernard Moss.^[1] It is used to designate viral proteins that interfere with immune response by reducing cytokine levels or effectiveness. They may do so by suppressing cytokine secretion, competing for cytokine receptors, interfering with cytokine signalling pathways, or otherwise antagonizing cytokines of the host organism. Many virokines are similar to host cytokines and may have been acquired by gene transfer from the host and subsequently modified.^[2]

[edit] Further reading

Girish J. Kotwal (1999). "Virokines: mediators of virus-host interaction and future immunomodulators in medicine" (PDF). Archivum Immunologiae et Therapiae Experimentalis (Warsz) 47 (3): 135–138. PMID 10470439.
Smith S.A. and Kotwal G.J. (May 2001). "Virokines: novel immunomodulatory agents". Expert Opinion on Biological Therapy 1 (3): 343–357.
MARIAM KLOUCHE, GIUSEPPE CARRUBA, LUIGI CASTAGNETTA, AND STEFAN ROSE-JOHN (December 2004). "Virokines in the Pathogenesis of Cancer: Focus on Human Herpesvirus". Annals of the. New York Academy of Sciences 1028: 329–339. DOI:10.1196/annals.1322.038.